INTS•benzinga•
Why Intensity Therapeutics (INTS) Stock Is Getting Hammered
Summary
Intensity Therapeutics shares are trading lower by 34.9% during Friday's session. The company announced the pricing of a public offering expected to raise approximately $2.35 million.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 25, 2025 by benzinga